Barbarella Fokos noon, Feb. 26
ResMed Stock Plunges Almost 14%
Stock of ResMed, which makes equipment for treating sleep-disordered breathing and various respiratory disorders, plummeted 13.66% today (Oct. 25) to $27.37. Third-quarter revenues rose 12%, but that was less than analysts had expected. Earnings per share fell 11 cents to 33 cents, 2 cents below estimates.